182 related articles for article (PubMed ID: 2444872)
1. Subcellular distribution and isolation of the Ca2+ antagonist receptor associated with the voltage regulated Ca2+ channel from rabbit heart muscle.
Tuana BS; Murphy BJ; Yi Q
Mol Cell Biochem; 1987 Aug; 76(2):173-84. PubMed ID: 2444872
[TBL] [Abstract][Full Text] [Related]
2. Calcium ions inhibit the allosteric interaction between the dihydropyridine and phenylalkylamine binding site on the voltage-gated calcium channel in heart sarcolemma but not in skeletal muscle transverse tubules.
Murphy BJ; Tuana BS
Can J Physiol Pharmacol; 1990 Nov; 68(11):1389-95. PubMed ID: 1962734
[TBL] [Abstract][Full Text] [Related]
3. The purified Ca2+ antagonist receptor from skeletal muscle: subunit structure, photoaffinity labeling and endogenous protein kinase activity.
Tuana BS; Murphy BJ; Yi Q
Mol Cell Biochem; 1988; 80(1-2):133-43. PubMed ID: 2845255
[TBL] [Abstract][Full Text] [Related]
4. Dihydropyridine binding to the L-type Ca2+ channel in rabbit heart sarcolemma and skeletal muscle transverse-tubules: role of disulfide, sulfhydryl and phosphate groups.
Murphy BJ; Washkurak AW; Tuana BS
Biochim Biophys Acta; 1990 May; 1052(2):333-9. PubMed ID: 2159349
[TBL] [Abstract][Full Text] [Related]
5. Dihydropyridine-sensitive Ca2+ channels: molecular properties of interaction with Ca2+ channel blockers, purification, subunit structure, and differentiation.
Lazdunski M; Barhanin J; Borsotto M; Fosset M; Galizzi JP; Renaud JF; Romey G; Schmid A
J Cardiovasc Pharmacol; 1986; 8 Suppl 8():S13-9. PubMed ID: 2433514
[TBL] [Abstract][Full Text] [Related]
6. The 1,4-dihydropyridine receptor associated with the skeletal muscle voltage-dependent Ca2+ channel. Purification and subunit composition.
Borsotto M; Barhanin J; Fosset M; Lazdunski M
J Biol Chem; 1985 Nov; 260(26):14255-63. PubMed ID: 2997201
[TBL] [Abstract][Full Text] [Related]
7. Solubilization of the nitrendipine receptor from skeletal muscle transverse tubule membranes. Interactions with specific inhibitors of the voltage-dependent Ca2+ channel.
Borsotto M; Norman RI; Fosset M; Lazdunski M
Eur J Biochem; 1984 Aug; 142(3):449-55. PubMed ID: 6088224
[TBL] [Abstract][Full Text] [Related]
8. Identification, characterization, and photoaffinity labeling of the dihydropyridine receptor associated with the L-type calcium channel from bovine adrenal medulla.
Murphy BJ; Rogers CA; Sunahara RK; Lemaire S; Tuana BS
Mol Pharmacol; 1990 Feb; 37(2):173-81. PubMed ID: 2154669
[TBL] [Abstract][Full Text] [Related]
9. Purification of the dihydropyridine receptor of the voltage-dependent Ca2+ channel from skeletal muscle transverse tubules using (+) [3H]PN 200-110.
Borsotto M; Barhanin J; Norman RI; Lazdunski M
Biochem Biophys Res Commun; 1984 Aug; 122(3):1357-66. PubMed ID: 6089781
[TBL] [Abstract][Full Text] [Related]
10. Structural characterization of the 1,4-dihydropyridine receptor of the voltage-dependent Ca2+ channel from rabbit skeletal muscle. Evidence for two distinct high molecular weight subunits.
Leung AT; Imagawa T; Campbell KP
J Biol Chem; 1987 Jun; 262(17):7943-6. PubMed ID: 2439496
[TBL] [Abstract][Full Text] [Related]
11. Putative Ca2+ channels in cardiac membranes. Subcellular distribution of [3H]nitrendipine receptors.
Haase H; Vetter R; Will H; Will-Shahab L
Biomed Biochim Acta; 1986; 45(1-2):S223-6. PubMed ID: 2421716
[TBL] [Abstract][Full Text] [Related]
12. Purification of the calcium antagonist receptor of the voltage-sensitive calcium channel from skeletal muscle transverse tubules.
Curtis BM; Catterall WA
Biochemistry; 1984 May; 23(10):2113-8. PubMed ID: 6329263
[TBL] [Abstract][Full Text] [Related]
13. Molecular approach to the calcium channel.
Glossmann H; Ferry DR; Goll A; Linn T
Adv Myocardiol; 1985; 5():41-76. PubMed ID: 2578683
[TBL] [Abstract][Full Text] [Related]
14. Binding Ca2+ to intracellular or to extracellular sites of dihydropyridine receptor of rabbit skeletal muscle discriminates between in vitro binding of Ca2+-channel agonist and antagonist.
Kanngiesser U; Pongs O
Eur J Biochem; 1989 May; 181(2):467-73. PubMed ID: 2540975
[TBL] [Abstract][Full Text] [Related]
15. Calcium channel agonist and antagonist binding in a highly enriched sarcolemma preparation obtained from canine ventricle.
Rampe D; Poder T; Zhao ZY; Schilling WP
J Cardiovasc Pharmacol; 1989 Apr; 13(4):547-56. PubMed ID: 2470991
[TBL] [Abstract][Full Text] [Related]
16. Binding of Ca2+ entry blockers to cardiac sarcolemmal membrane vesicles. Characterization of diltiazem-binding sites and their interaction with dihydropyridine and aralkylamine receptors.
Garcia ML; King VF; Siegl PK; Reuben JP; Kaczorowski GJ
J Biol Chem; 1986 Jun; 261(18):8146-57. PubMed ID: 2424894
[TBL] [Abstract][Full Text] [Related]
17. The bovine cardiac receptor for calcium channel blockers is a 195-kDa protein.
Schneider T; Hofmann F
Eur J Biochem; 1988 Jun; 174(2):369-75. PubMed ID: 2838274
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibodies that coimmunoprecipitate the 1,4-dihydropyridine and phenylalkylamine receptors and reveal the Ca2+ channel structure.
Vandaele S; Fosset M; Galizzi JP; Lazdunski M
Biochemistry; 1987 Jan; 26(1):5-9. PubMed ID: 2435317
[TBL] [Abstract][Full Text] [Related]
19. Purification of a functional receptor for calcium-channel blockers from rabbit skeletal-muscle microsomes.
Flockerzi V; Oeken HJ; Hofmann F
Eur J Biochem; 1986 Nov; 161(1):217-24. PubMed ID: 3023084
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of purified bovine cardiac sarcolemma and potassium-stimulated calcium uptake.
Flockerzi V; Mewes R; Ruth P; Hofmann F
Eur J Biochem; 1983 Sep; 135(1):131-42. PubMed ID: 6309517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
